Register entry
ASCENDIS PHARMA GROWTH DISORDERS AS
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 36
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
36| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8906847 | YUVIWELnavepegritide | substance, product | Apr 2031 |
| 10835578 | YUVIWELnavepegritide | substance, product | Jan 2037 |
| 11154593 | YUVIWELnavepegritide | substance, product | Jan 2037 |
| 11224661 | YUVIWELnavepegritide | substance, product | Jan 2037 |
| 11311604 | YUVIWELnavepegritide | substance, product | Jan 2037 |
| 11389510 | YUVIWELnavepegritide | substance, product | Jan 2037 |
| 11389511 | YUVIWELnavepegritide | product | Jan 2037 |
| 11413351 | YUVIWELnavepegritide | substance, product | Jan 2037 |
| 12083182 | YUVIWELnavepegritide | use | Jan 2037 |
| 12156917 | YUVIWELnavepegritide | use | Jan 2037 |
| 12239689 | YUVIWELnavepegritide | use | Jan 2037 |
| 12377133 | YUVIWELnavepegritide | product | Nov 2042 |
| Product | Exclusivity | Until |
|---|---|---|
| YUVIWELNAVEPEGRITIDE | ODE-516 Orphan drug | Feb 2033 |
Enquiry
Common questions
- Is ASCENDIS PHARMA GROWTH DISORDERS AS FDA approved?
- ASCENDIS PHARMA GROWTH DISORDERS AS holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.